I'll answer it in two ways. First of all, they have particular programs in place that fund medicinal chemistry, which actually fund drug discovery. It's not tacked on to some other particular funding agency.
As already mentioned, for example, in the United States they have SBIR, so they have particular programs that are probably better at encouraging this sort of translation.